204 related articles for article (PubMed ID: 34584067)
41. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway.
Han F; Xu Q; Zhao J; Xiong P; Liu J
J Cell Biochem; 2018 Nov; 119(11):8996-9005. PubMed ID: 30076651
[TBL] [Abstract][Full Text] [Related]
42. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
43. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway.
Liu SL; Cai C; Yang ZY; Wu ZY; Wu XS; Wang XF; Dong P; Gong W
Int J Biol Sci; 2021; 17(2):498-513. PubMed ID: 33613108
[TBL] [Abstract][Full Text] [Related]
44. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
45. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
46. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
47. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of FoxM1 promotes differentiation of bone marrow mesenchymal stem cells into alveolar type II cells through activating Wnt/β-catenin signalling.
Zeng M; Chen Q; Ge S; He W; Zhang L; Yi H; Lin S
Biochem Biophys Res Commun; 2020 Jul; 528(2):311-317. PubMed ID: 32475644
[TBL] [Abstract][Full Text] [Related]
49. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
50. FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes.
Wang X; Dou N; Wang J; Zhang Y; Li Y; Gao Y
Int J Biol Sci; 2021; 17(4):915-925. PubMed ID: 33867818
[TBL] [Abstract][Full Text] [Related]
51. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
[TBL] [Abstract][Full Text] [Related]
52. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
53. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
54. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
[TBL] [Abstract][Full Text] [Related]
55. FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways.
Wu SQ; Huang SH; Lin QW; Tang YX; Huang L; Xu YG; Wang SP
Pharmacol Res; 2022 Jan; 175():106040. PubMed ID: 34954029
[TBL] [Abstract][Full Text] [Related]
56. E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway.
Zhao H; Zhao C; Li H; Zhang D; Liu G
J Exp Clin Cancer Res; 2019 Jun; 38(1):276. PubMed ID: 31234887
[TBL] [Abstract][Full Text] [Related]
57. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
58. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
59. PELI1 overexpression contributes to pancreatic cancer progression through upregulating ubiquitination-mediated INPP5J degradation.
Zhou W; Deng X; Liu L; Yuan Y; Meng X; Ma J
Cell Signal; 2024 Aug; 120():111194. PubMed ID: 38685520
[TBL] [Abstract][Full Text] [Related]
60. FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.
Arceci A; Bonacci T; Wang X; Stewart K; Damrauer JS; Hoadley KA; Emanuele MJ
Cell Rep; 2019 Mar; 26(11):3076-3086.e6. PubMed ID: 30865895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]